Published in Healthcare Finance, Tax and Law Weekly, June 10th, 2009
J.P. Morgan Securities Inc. is acting as sole book-running manager of the offering.
The company currently expects to use the net proceeds of this offering for general corporate purposes, including to support further research, development and commercialization of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.